Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$660M |
| 2 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$173M |
| 3 |
Altria Group
MO
|
+$145M |
| 4 |
Verizon
VZ
|
+$134M |
| 5 |
United Parcel Service
UPS
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$181M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$148M |
| 3 |
Apple
AAPL
|
+$127M |
| 4 |
abrdn Physical Gold Shares ETF
SGOL
|
+$106M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 12.48% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLR
1876
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $9.82M | ﹤0.01% |
602,720
+47,060
| +8% | +$703K |
|
1877
AMERISAFE
AMSF
$564M
| $9.82M | ﹤0.01% |
170,928
+3,478
| +2% | +$201K |
|
|
AXNX
1878
DELISTED
Axonics, Inc. Common Stock
AXNX
| $9.78M | ﹤0.01% |
195,889
+3,178
| +2% | +$149K |
|
1879
Celsius Holdings
CELH
$7.22B
| $9.77M | ﹤0.01% |
582,780
+20,451
| +4% | +$204K |
|
1880
Vroom Inc
VRM
$37.2M
| $9.75M | ﹤0.01% |
2,975
+207
| +7% | +$683K |
|
1881
Pennant Group
PNTG
$1.4B
| $9.74M | ﹤0.01% |
167,760
+3,569
| +2% | +$172K |
|
|
PS
1882
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $9.72M | ﹤0.01% |
463,705
+10,967
| +2% | +$196K |
|
1883
Flex
FLEX
$43.4B
| $9.71M | ﹤0.01% |
716,441
-44,144
| -6% | -$510K |
|
|
TVTY
1884
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $9.71M | ﹤0.01% |
495,538
-12,782
| -3% | -$212K |
|
1885
Inovio Pharmaceuticals
INO
$72M
| $9.7M | ﹤0.01% |
91,290
+1,614
| +2% | +$215K |
|
|
SLCA
1886
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $9.66M | ﹤0.01% |
1,376,443
-3,164
| -0.2% | -$13.7K |
|
|
NXGN
1887
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $9.66M | ﹤0.01% |
529,742
+17,307
| +3% | +$275K |
|
1888
Virtu Financial
VIRT
$5.2B
| $9.65M | ﹤0.01% |
383,469
+18,052
| +5% | +$418K |
|
|
SC
1889
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $9.64M | ﹤0.01% |
437,953
-5,033
| -1% | -$109K |
|
|
TBIO
1890
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $9.64M | ﹤0.01% |
523,230
+68,912
| +15% | +$1.23M |
|
1891
Griffon
GFF
$4.1B
| $9.64M | ﹤0.01% |
472,911
+10,619
| +2% | +$228K |
|
|
WW
1892
DELISTED
WW International
WW
| $9.61M | ﹤0.01% |
393,968
+8,972
| +2% | +$233K |
|
|
FSR
1893
DELISTED
Fisker Inc.
FSR
| $9.6M | ﹤0.01% |
+655,527
| New | +$9.64M |
|
1894
Standex International
SXI
$3.78B
| $9.56M | ﹤0.01% |
123,321
+393
| +0.3% | +$28K |
|
|
MRSN
1895
DELISTED
Mersana Therapeutics
MRSN
| $9.53M | ﹤0.01% |
14,330
+191
| +1% | +$106K |
|
1896
Cytokinetics
CYTK
$10.4B
| $9.52M | ﹤0.01% |
458,182
+9,331
| +2% | +$171K |
|
|
DCH
1897
Dauch Corp
DCH
$1.38B
| $9.49M | ﹤0.01% |
1,138,061
+29,823
| +3% | +$224K |
|
1898
OFG Bancorp
OFG
$2.24B
| $9.47M | ﹤0.01% |
510,923
+15,463
| +3% | +$250K |
|
1899
Stride
LRN
$3.41B
| $9.47M | ﹤0.01% |
446,113
+588
| +0.1% | +$14.6K |
|
|
EIDX
1900
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $9.45M | ﹤0.01% |
71,774
-21,553
| -23% | -$1.9M |
|
Similar funds
Charles Schwab's Q4 2020 Portfolio in Review
As of Q4 2020, Charles Schwab held 3,457 positions worth $252B, up 16% from $217B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q4 2020 filing shows 113 new, 2,243 increased, 711 reduced and 62 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M. The largest sale was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2020 buy was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M.
- Charles Schwab added most to Tesla in Q4 2020, an estimated $660M increase.
- Charles Schwab's biggest Q4 2020 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $181M.
- Charles Schwab fully exited iShares MSCI Germany ETF in Q4 2020, selling an estimated $148M.
- Charles Schwab's ten largest holdings make up 17% of its $252B portfolio in Q4 2020.
- Charles Schwab opened 113 new positions and closed 62 in Q4 2020.
- Charles Schwab's portfolio value rose 16% quarter-over-quarter to $252B.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.